TCL Archive Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure? September 2, 1977
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: Broder Wins ARC’s Griffuel Prize; Lawyers Trained To Help Low-Income Breast Ca, Patients October 16, 1992
